Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 213

1.

Inflammatory and immunometabolic consequences of gut dysfunction in HIV: Parallels with IBD and implications for reservoir persistence and non-AIDS comorbidities.

Alzahrani J, Hussain T, Simar D, Palchaudhuri R, Abdel-Mohsen M, Crowe SM, Mbogo GW, Palmer CS.

EBioMedicine. 2019 Aug;46:522-531. doi: 10.1016/j.ebiom.2019.07.027. Epub 2019 Jul 18. Review.

2.

People who inject drugs in Bangladesh - The untold burden!

Khan SI, Reza MM, Crowe SM, Rahman M, Hellard M, Sarker MS, Chowdhury EI, Rana AKMM, Sacks-Davis R, Banu S, Ross AG.

Int J Infect Dis. 2019 Jun;83:109-115. doi: 10.1016/j.ijid.2019.03.009. Epub 2019 Mar 27. Review.

3.

Qualitative assessment of South African healthcare worker perspectives on an instrument-free rapid CD4 test.

Scorgie F, Mohamed Y, Anderson D, Crowe SM, Luchters S, Chersich MF.

BMC Health Serv Res. 2019 Feb 14;19(1):123. doi: 10.1186/s12913-019-3948-x.

4.

Performance of a Novel Low-Cost, Instrument-Free Plasma Separation Device for HIV Viral Load Quantification and Determination of Treatment Failure in People Living with HIV in Malaysia: a Diagnostic Accuracy Study.

Pham MD, Haile BA, Azwa I, Kamarulzaman A, Raman N, Saeidi A, Kahar Bador M, Tan M, Zhu J, Feng Y, Elliott JH, Garcia ML, Li F, Crowe SM, Luchters S, Anderson DA.

J Clin Microbiol. 2019 Mar 28;57(4). pii: e01683-18. doi: 10.1128/JCM.01683-18. Print 2019 Apr.

5.

A Bioelectronic System to Measure the Glycolytic Metabolism of Activated CD4+ T Cells.

Crowe SM, Kintzios S, Kaltsas G, Palmer CS.

Biosensors (Basel). 2019 Jan 9;9(1). pii: E10. doi: 10.3390/bios9010010.

6.

Field Performance and Diagnostic Accuracy of a Low-Cost Instrument-Free Point-of-Care CD4 Test (Visitect CD4) Performed by Different Health Worker Cadres among Pregnant Women.

Luchters S, Technau K, Mohamed Y, Chersich MF, Agius PA, Pham MD, Garcia ML, Forbes J, Shepherd A, Coovadia A, Crowe SM, Anderson DA.

J Clin Microbiol. 2019 Jan 30;57(2). pii: e01277-18. doi: 10.1128/JCM.01277-18. Print 2019 Feb.

7.

Induction of HIF-1α by HIV-1 Infection in CD4+ T Cells Promotes Viral Replication and Drives Extracellular Vesicle-Mediated Inflammation.

Duette G, Pereyra Gerber P, Rubione J, Perez PS, Landay AL, Crowe SM, Liao Z, Witwer KW, Holgado MP, Salido J, Geffner J, Sued O, Palmer CS, Ostrowski M.

mBio. 2018 Sep 11;9(5). pii: e00757-18. doi: 10.1128/mBio.00757-18.

8.

Suppression of monocyte inflammatory and coagulopathy responses in HIV infection.

Rajasuriar R, Hearps AC, Crowe SM, Anzinger JJ, Palmer CS.

Ann Transl Med. 2018 Jul;6(13):277. doi: 10.21037/atm.2018.06.20. No abstract available.

9.

Polymorphism rs1385129 Within Glut1 Gene SLC2A1 Is Linked to Poor CD4+ T Cell Recovery in Antiretroviral-Treated HIV+ Individuals.

Masson JJR, Cherry CL, Murphy NM, Sada-Ovalle I, Hussain T, Palchaudhuri R, Martinson J, Landay AL, Billah B, Crowe SM, Palmer CS.

Front Immunol. 2018 May 17;9:900. doi: 10.3389/fimmu.2018.00900. eCollection 2018.

10.

A tale of two countries: progress towards UNAIDS 90-90-90 targets in Botswana and Australia.

Marukutira T, Stoové M, Lockman S, Mills LA, Gaolathe T, Lebelonyane R, Jarvis JN, Kelly SL, Wilson DP, Luchters S, Crowe SM, Hellard M.

J Int AIDS Soc. 2018 Mar;21(3). doi: 10.1002/jia2.25090.

11.

Exploiting immune cell metabolic machinery for functional HIV cure and the prevention of inflammaging.

Palmer CS, Palchaudhuri R, Albargy H, Abdel-Mohsen M, Crowe SM.

F1000Res. 2018 Jan 30;7:125. doi: 10.12688/f1000research.11881.1. eCollection 2018. Review.

12.

Sugar or Fat?-Metabolic Requirements for Immunity to Viral Infections.

Shehata HM, Murphy AJ, Lee MKS, Gardiner CM, Crowe SM, Sanjabi S, Finlay DK, Palmer CS.

Front Immunol. 2017 Oct 16;8:1311. doi: 10.3389/fimmu.2017.01311. eCollection 2017. Review.

13.

Glut1 Expression Level on Inflammatory Monocytes is Associated With Markers of Cardiovascular Disease Risk in HIV-Infected Individuals.

Anzinger JJ, Butterfield TR, Gouillou M, McCune JM, Crowe SM, Palmer CS.

J Acquir Immune Defic Syndr. 2018 Feb 1;77(2):e28-e30. doi: 10.1097/QAI.0000000000001559. No abstract available.

PMID:
28961681
14.

Metabolically active CD4+ T cells expressing Glut1 and OX40 preferentially harbor HIV during in vitro infection.

Palmer CS, Duette GA, Wagner MCE, Henstridge DC, Saleh S, Pereira C, Zhou J, Simar D, Lewin SR, Ostrowski M, McCune JM, Crowe SM.

FEBS Lett. 2017 Oct;591(20):3319-3332. doi: 10.1002/1873-3468.12843. Epub 2017 Oct 11.

15.

Assessment of metabolic and mitochondrial dynamics in CD4+ and CD8+ T cells in virologically suppressed HIV-positive individuals on combination antiretroviral therapy.

Masson JJR, Murphy AJ, Lee MKS, Ostrowski M, Crowe SM, Palmer CS.

PLoS One. 2017 Aug 30;12(8):e0183931. doi: 10.1371/journal.pone.0183931. eCollection 2017.

16.

Immunometabolic and Lipidomic Markers Associated With the Frailty Index and Quality of Life in Aging HIV+ Men on Antiretroviral Therapy.

Yeoh HL, Cheng AC, Cherry CL, Weir JM, Meikle PJ, Hoy JF, Crowe SM, Palmer CS.

EBioMedicine. 2017 Aug;22:112-121. doi: 10.1016/j.ebiom.2017.07.015. Epub 2017 Jul 18.

17.

Frailty in men living with HIV: a cross-sectional comparison of three frailty instruments.

Yeoh HL, Cheng A, Palmer C, Crowe SM, Hoy JF.

Antivir Ther. 2018;23(2):117-127. doi: 10.3851/IMP3185.

PMID:
28731422
18.

Less frequent CD4 monitoring in virologically suppressed HIV.

McMahon J, Crowe SM.

Lancet HIV. 2017 Jun;4(6):e233-e234. doi: 10.1016/S2352-3018(17)30070-X. Epub 2017 Apr 11. No abstract available.

PMID:
28411090
19.

Major health impact of accelerated aging in young HIV-infected individuals on antiretroviral therapy.

Rajasuriar R, Chong ML, Ahmad Bashah NS, Abdul Aziz SA, Mcstea M, Lee ECY, Wong PL, Azwa I, Syed Omar SF, Lai PSM, Ponampalavanar S, Crowe SM, Lewin SR, Kamaruzzaman SB, Kamarulzaman A.

AIDS. 2017 Jun 19;31(10):1393-1403. doi: 10.1097/QAD.0000000000001475.

PMID:
28358731
20.

High Levels of Transmitted HIV Drug Resistance in a Study in Papua New Guinea.

Lavu E, Kave E, Mosoro E, Markby J, Aleksic E, Gare J, Elsum IA, Nano G, Kaima P, Dala N, Gurung A, Bertagnolio S, Crowe SM, Myatt M, Hearps AC, Jordan MR.

PLoS One. 2017 Feb 1;12(2):e0170265. doi: 10.1371/journal.pone.0170265. eCollection 2017.

21.

Feasibility of antiretroviral treatment monitoring in the era of decentralized HIV care: a systematic review.

Pham MD, Romero L, Parnell B, Anderson DA, Crowe SM, Luchters S.

AIDS Res Ther. 2017 Jan 19;14(1):3. doi: 10.1186/s12981-017-0131-5. Review.

22.

Decreased levels of platelet-derived soluble glycoprotein VI detected prior to the first diagnosis of coronary artery disease in HIV-positive individuals.

Trevillyan JM, Gardiner EE, Andrews RK, Maisa A, Hearps AC, Al-Tamimi M, Crowe SM, Hoy JF.

Platelets. 2017 May;28(3):301-304. doi: 10.1080/09537104.2016.1237627. Epub 2016 Nov 16.

PMID:
27848272
23.

Increased glucose transporter-1 expression on intermediate monocytes from HIV-infected women with subclinical cardiovascular disease.

Butterfield TR, Hanna DB, Kaplan RC, Kizer JR, Durkin HG, Young MA, Nowicki MJ, Tien PC, Golub ET, Floris-Moore MA, Titanji K, Fischl MA, Heath SL, Martinson J, Crowe SM, Palmer CS, Landay AL, Anzinger JJ.

AIDS. 2017 Jan 14;31(2):199-205. doi: 10.1097/QAD.0000000000001320.

24.

Immunometabolism may provide new insights into novel mechanisms of HIV reservoir persistence.

Palmer CS, Crowe SM.

AIDS. 2016 Nov 28;30(18):2895-2896. No abstract available.

PMID:
27824628
25.

Performance of point-of-care CD4 testing technologies in resource-constrained settings: a systematic review and meta-analysis.

Pham MD, Agius PA, Romero L, McGlynn P, Anderson D, Crowe SM, Luchters S.

BMC Infect Dis. 2016 Oct 21;16(1):592.

26.

A Simple Flow Cytometric Method to Measure Glucose Uptake and Glucose Transporter Expression for Monocyte Subpopulations in Whole Blood.

Palmer CS, Anzinger JJ, Butterfield TR, McCune JM, Crowe SM.

J Vis Exp. 2016 Aug 12;(114). doi: 10.3791/54255.

27.

Genetic polymorphisms in the CD14 gene are associated with monocyte activation and carotid intima-media thickness in HIV-infected patients on antiretroviral therapy.

Yong YK, Shankar EM, Westhorpe CL, Maisa A, Spelman T, Kamarulzaman A, Crowe SM, Lewin SR.

Medicine (Baltimore). 2016 Aug;95(31):e4477. doi: 10.1097/MD.0000000000004477.

28.

Acceptability and feasibility of point-of-care CD4 testing on HIV continuum of care in low and middle income countries: a systematic review.

Pham MD, Agius PA, Romero L, McGlynn P, Anderson D, Crowe SM, Luchters S.

BMC Health Serv Res. 2016 Aug 2;16(a):343. doi: 10.1186/s12913-016-1588-y.

29.

Glucose Metabolism in T Cells and Monocytes: New Perspectives in HIV Pathogenesis.

Palmer CS, Cherry CL, Sada-Ovalle I, Singh A, Crowe SM.

EBioMedicine. 2016 Apr;6:31-41. doi: 10.1016/j.ebiom.2016.02.012. Epub 2016 Feb 6. Review.

30.

Emerging Role and Characterization of Immunometabolism: Relevance to HIV Pathogenesis, Serious Non-AIDS Events, and a Cure.

Palmer CS, Henstridge DC, Yu D, Singh A, Balderson B, Duette G, Cherry CL, Anzinger JJ, Ostrowski M, Crowe SM.

J Immunol. 2016 Jun 1;196(11):4437-44. doi: 10.4049/jimmunol.1600120. Review.

31.

Aberrant Inflammasome Activation Characterizes Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome.

Tan HY, Yong YK, Shankar EM, Paukovics G, Ellegård R, Larsson M, Kamarulzaman A, French MA, Crowe SM.

J Immunol. 2016 May 15;196(10):4052-63. doi: 10.4049/jimmunol.1502203. Epub 2016 Apr 13.

32.

Regulators of Glucose Metabolism in CD4+ and CD8+ T Cells.

Palmer CS, Hussain T, Duette G, Weller TJ, Ostrowski M, Sada-Ovalle I, Crowe SM.

Int Rev Immunol. 2016 Nov;35(6):477-488. Epub 2015 Nov 25. Review.

PMID:
26606199
33.

Panobinostat clinical trial highlights the challenges towards an HIV cure.

Palmer CS, Crowe SM.

Lancet HIV. 2014 Dec;1(3):e103. doi: 10.1016/S2352-3018(14)00009-5. Epub 2014 Nov 24. No abstract available.

PMID:
26424118
34.

Planning for the Next Global Pandemic.

Ross AG, Crowe SM, Tyndall MW.

Int J Infect Dis. 2015 Sep;38:89-94. doi: 10.1016/j.ijid.2015.07.016. Epub 2015 Aug 4.

35.

Factors Influencing Antiretroviral Adherence and Virological Outcomes in People Living with HIV in the Highlands of Papua New Guinea.

Gare J, Kelly-Hanku A, Ryan CE, David M, Kaima P, Imara U, Lote N, Crowe SM, Hearps AC.

PLoS One. 2015 Aug 5;10(8):e0134918. doi: 10.1371/journal.pone.0134918. eCollection 2015.

36.

Monocytes from HIV-infected individuals show impaired cholesterol efflux and increased foam cell formation after transendothelial migration.

Maisa A, Hearps AC, Angelovich TA, Pereira CF, Zhou J, Shi MD, Palmer CS, Muller WA, Crowe SM, Jaworowski A.

AIDS. 2015 Jul 31;29(12):1445-57. doi: 10.1097/QAD.0000000000000739.

37.

Quantitative Assessment of Intra-Patient Variation in CD4+ T Cell Counts in Stable, Virologically-Suppressed, HIV-Infected Subjects.

Gordon CL, Cheng AC, Cameron PU, Bailey M, Crowe SM, Mills J.

PLoS One. 2015 Jun 25;10(6):e0125248. doi: 10.1371/journal.pone.0125248. eCollection 2015.

38.

The dire sexual health crisis among MSM in the Philippines: an exploding HIV epidemic in the absence of essential health services.

Ross AG, Ditangco RA, Belimac JG, Olveda RM, Mercado ES, Chau TN, Crowe SM.

Int J Infect Dis. 2015 Aug;37:6-8. doi: 10.1016/j.ijid.2015.06.001. Epub 2015 Jun 10.

39.

CD4 enumeration technologies: a systematic review of test performance for determining eligibility for antiretroviral therapy.

Peeling RW, Sollis KA, Glover S, Crowe SM, Landay AL, Cheng B, Barnett D, Denny TN, Spira TJ, Stevens WS, Crowley S, Essajee S, Vitoria M, Ford N.

PLoS One. 2015 Mar 19;10(3):e0115019. doi: 10.1371/journal.pone.0115019. eCollection 2015. Review.

40.

HIV eradication symposium: will the brain be left behind?

Brew BJ, Robertson K, Wright EJ, Churchill M, Crowe SM, Cysique LA, Deeks S, Garcia JV, Gelman B, Gray LR, Johnson T, Joseph J, Margolis DM, Mankowski JL, Spencer B.

J Neurovirol. 2015 Jun;21(3):322-34. doi: 10.1007/s13365-015-0322-6. Epub 2015 Mar 7.

41.

Glucose metabolism regulates T cell activation, differentiation, and functions.

Palmer CS, Ostrowski M, Balderson B, Christian N, Crowe SM.

Front Immunol. 2015 Jan 22;6:1. doi: 10.3389/fimmu.2015.00001. eCollection 2015. Review.

42.

Viremic and Virologically Suppressed HIV Infection Increases Age-Related Changes to Monocyte Activation Equivalent to 12 and 4 Years of Aging, Respectively.

Angelovich TA, Hearps AC, Maisa A, Martin GE, Lichtfuss GF, Cheng WJ, Palmer CS, Landay AL, Crowe SM, Jaworowski A.

J Acquir Immune Defic Syndr. 2015 May 1;69(1):11-7. doi: 10.1097/QAI.0000000000000559.

PMID:
25647525
43.

Plasma interleukin-18 levels are a biomarker of innate immune responses that predict and characterize tuberculosis-associated immune reconstitution inflammatory syndrome.

Tan HY, Yong YK, Andrade BB, Shankar EM, Ponnampalavanar S, Omar SF, Narendran G, Kamarulzaman A, Swaminathan S, Sereti I, Crowe SM, French MA.

AIDS. 2015 Feb 20;29(4):421-31. doi: 10.1097/QAD.0000000000000557.

PMID:
25565499
44.

C-reactive protein as a predictor of cardiovascular risk in HIV-infected individuals.

Westhorpe CL, Schneider HG, Dunne M, Middleton T, Sundararajan V, Spelman T, Carter V, Crowe SM, Dart A, Mijch A, Kotsanas D, Woolley I.

Sex Health. 2014 Dec;11(6):580-2. doi: 10.1071/SH14130.

PMID:
25435195
45.

Glucose transporter 1-expressing proinflammatory monocytes are elevated in combination antiretroviral therapy-treated and untreated HIV+ subjects.

Palmer CS, Anzinger JJ, Zhou J, Gouillou M, Landay A, Jaworowski A, McCune JM, Crowe SM.

J Immunol. 2014 Dec 1;193(11):5595-603. doi: 10.4049/jimmunol.1303092. Epub 2014 Nov 3.

46.

Macrophage migration inhibitory factor: a potential biomarker for cardiovascular disease in persons with HIV?

Woolley IJ, Ayoub S, Crowe SM, Westhorpe C, Cherry CL, Visvanathan K, Morand E.

AIDS. 2014 Jul 17;28(11):1693-4. doi: 10.1097/QAD.0000000000000276. No abstract available.

PMID:
25232902
47.

Tuberculosis (TB)-associated immune reconstitution inflammatory syndrome in TB-HIV co-infected patients in Malaysia: prevalence, risk factors, and treatment outcomes.

Tan HY, Yong YK, Lim SH, Ponnampalavanar S, Omar SF, Pang YK, Kamarulzaman A, Price P, Crowe SM, French MA.

Sex Health. 2014 Dec;11(6):532-9. doi: 10.1071/SH14093.

PMID:
25200957
48.

The importance of monocytes and macrophages in HIV pathogenesis, treatment, and cure.

Campbell JH, Hearps AC, Martin GE, Williams KC, Crowe SM.

AIDS. 2014 Sep 24;28(15):2175-87. doi: 10.1097/QAD.0000000000000408. Review.

49.

Monocytes as regulators of inflammation and HIV-related comorbidities during cART.

Anzinger JJ, Butterfield TR, Angelovich TA, Crowe SM, Palmer CS.

J Immunol Res. 2014;2014:569819. doi: 10.1155/2014/569819. Epub 2014 Jun 12. Review.

50.

Presence of HIV drug resistance in antiretroviral therapy-naive and -experienced patients from Papua New Guinea.

Gare J, Ryan CE, David M, Timbi D, Kaima P, Kombati Z, Imara U, Kelly-Hanku A, Siba PM, Crowe SM, Hearps AC.

J Antimicrob Chemother. 2014 Aug;69(8):2183-6. doi: 10.1093/jac/dku089. Epub 2014 Apr 9.

PMID:
24722838

Supplemental Content

Loading ...
Support Center